The human cost of Herceptin - how other cancer patients pay the price

Doctors have calculated that their trust will have to cut £2.3 million from cancer services to implement NICE guidance on Herceptin.

Herceptin
Herceptin

New guidance from NICE recommends trastuzumab (Herceptin) in early breast cancer but provides no extra funding.

Doctors at the Norfolk and Norwich University Hospital NHS Trust and the University of East Anglia said they would have to find £1.9 million a year to make Herceptin available to the patients who may be eligible. This becomes £2.3 million when the costs of testing and monitoring patients are added.

After auditing drug costs in their hospital’s cancer centre, they estimated that they could save £1.9 million by cutting chemotherapy and palliative care treatments.

This would enable them to treat 75 patients with Herceptin, but they would have to stop 355 patients receiving adjuvant treatment (16 of whom would be cured) or 208 patients receiving palliative chemotherapy.

Writing in the BMJ, the doctors argue that NICE should be given responsibility to decide what to cut to fund newly recommended technologies, or have the ability to allocate extra funds, rather than leaving rationing decisions to medical staff.

MIMS link

Cancer

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NICE recommends digital CBT for children with mild depression

NICE recommends digital CBT for children with mild depression

Children and young people with mild depression should have access to digital cognitive...

GPs taking early retirement triple in a decade as tax limits hit workforce

GPs taking early retirement triple in a decade as tax limits hit workforce

Numbers of GPs taking early retirement have tripled over the past decade as tighter...

BMA safety warning as pharmacists gain power to switch prescriptions

BMA safety warning as pharmacists gain power to switch prescriptions

Pharmacists are set to be granted emergency powers to alter patients' prescriptions...

GP funding could rise £60m through deals on QOF, networks and digital health

GP funding could rise £60m through deals on QOF, networks and digital health

GP leaders hope to trigger a 1% boost to practice funding from April - on top of...

GP trainees unfairly denied £20,000 golden hello payments, says BMA

GP trainees unfairly denied £20,000 golden hello payments, says BMA

Some GP trainees expecting £20,000 golden hellos for working in under-doctored areas...

The survival of GP partnerships depends on a credible workforce plan

The survival of GP partnerships depends on a credible workforce plan

The GP partnership review and the NHS long-term plan set out welcome proposals to...